SG11201808514YA - Method for designing mutant primer - Google Patents

Method for designing mutant primer

Info

Publication number
SG11201808514YA
SG11201808514YA SG11201808514YA SG11201808514YA SG11201808514YA SG 11201808514Y A SG11201808514Y A SG 11201808514YA SG 11201808514Y A SG11201808514Y A SG 11201808514YA SG 11201808514Y A SG11201808514Y A SG 11201808514YA SG 11201808514Y A SG11201808514Y A SG 11201808514YA
Authority
SG
Singapore
Prior art keywords
primer
nucleotide residue
region
loop structure
designing
Prior art date
Application number
SG11201808514YA
Other languages
English (en)
Inventor
Makoto Takaishi
Original Assignee
Daiken Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiken Medical Co Ltd filed Critical Daiken Medical Co Ltd
Priority claimed from PCT/JP2017/004162 external-priority patent/WO2017169119A1/ja
Publication of SG11201808514YA publication Critical patent/SG11201808514YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201808514YA 2016-03-30 2017-02-06 Method for designing mutant primer SG11201808514YA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016067252 2016-03-30
JP2016154013A JP6681804B2 (ja) 2016-03-30 2016-08-04 変異プライマーの設計方法
PCT/JP2017/004162 WO2017169119A1 (ja) 2016-03-30 2017-02-06 変異プライマーの設計方法

Publications (1)

Publication Number Publication Date
SG11201808514YA true SG11201808514YA (en) 2018-10-30

Family

ID=60044331

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201808514YA SG11201808514YA (en) 2016-03-30 2017-02-06 Method for designing mutant primer

Country Status (8)

Country Link
US (1) US20190144933A1 (ja)
EP (1) EP3438257A4 (ja)
JP (1) JP6681804B2 (ja)
KR (1) KR20180129806A (ja)
CN (1) CN109072221A (ja)
CA (1) CA3019468A1 (ja)
SG (1) SG11201808514YA (ja)
ZA (1) ZA201806890B (ja)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE280177T1 (de) * 1997-03-20 2004-11-15 Hoffmann La Roche Modifizierte primer
ES2254306T3 (es) * 2000-10-25 2006-06-16 F. Hoffmann-La Roche Ag Amplificacion usando cebadores modificados.
WO2006112818A2 (en) * 2005-04-14 2006-10-26 Applera Corporation 3' modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and applications thereof as primers or probes
ES2647237T3 (es) * 2007-07-03 2017-12-20 Genaphora Ltd. Cebadores quiméricos para reacciones de amplificación de ácidos nucleicos mejoradas
KR101110013B1 (ko) * 2007-10-05 2012-02-29 (주)바이오니아 서열 내에 어베이직 부분을 포함하는 ｐｃｒ 증폭용프라이머
US9783844B2 (en) * 2012-04-27 2017-10-10 Kaneka Corporation Method for amplifying nucleic acid and method for detecting amplified nucleic acid
JP5944999B2 (ja) * 2012-07-03 2016-07-05 マッカイ メモリアル ホスピタルＭａｃｋａｙ Ｍｅｍｏｒｉａｌ Ｈｏｓｐｉｔａｌ 自己競合型プライマーおよびこの自己競合型プライマーの使用方法
US10961567B2 (en) * 2016-02-25 2021-03-30 Roche Sequencing Solutions, Inc. Elimination of primer-primer interactions during primer extension

Also Published As

Publication number Publication date
JP6681804B2 (ja) 2020-04-15
EP3438257A4 (en) 2019-10-23
EP3438257A1 (en) 2019-02-06
CN109072221A (zh) 2018-12-21
US20190144933A1 (en) 2019-05-16
JP2017184710A (ja) 2017-10-12
KR20180129806A (ko) 2018-12-05
ZA201806890B (en) 2020-01-29
CA3019468A1 (en) 2017-10-05

Similar Documents

Publication Publication Date Title
MX2018004284A (es) Metodos y composiciones para el enriquecimiento de productos de amplificacion.
MX2022005119A (es) Metodos de reduccion de olor.
MX2009008958A (es) Metodo para separar halocarburos.
MY148378A (en) Process for producing an organic compound
SG10201900355RA (en) Polypeptide for hydrolytic cleavage of zearalenone and/orzearalenone derivatives, isolated polynucleotide thereof as wellas a polypeptide containing an additive, use of same as well as aprocess
NZ631512A (en) Compositions and methods for modulating apolipoprotein (a) expression
PH12015502388A1 (en) Compositions and methods for altering second messenger signaling
UA99936C2 (en) Biaryl substituted azabicyclic alkane derivatives
TW200630385A (en) Process for the polymerisation of vinyl-containing monomers
FR3023840B1 (fr) Procede de production de paraxylene a haute purete a partir d'une coupe xylenes, utilisant deux unites de separation en lit mobile simule fonctionnant en serie et deux unites d'isomerisation.
MX2012011219A (es) Separacion de compuestos de punto de ebullicion cercano mediante la adicion de un tercer compuesto.
MX2010009081A (es) Procesos para separar 1,3,3,3-tetrafluoropropeno de fluoruro de hidrogeno mediante destilacion azeotropica.
IN2014CN04648A (ja)
MX2013012079A (es) Emulsion de cera para uso en productos para la construccion.
MX2021013038A (es) Composiciones que contienen hfo-1234ze, hfo-1225zc y hfo-1234yf y procesos para producir y usar las composiciones.
GB2489187A (en) Compositions,methods and related uses for cleaving modified DNA
MX363238B (es) Proceso enzimatico para obtener 17 alfa-monoesteres de cortexolona y/o sus 9,11-dehidroderivados.
MX346019B (es) Kit para detectar el virus de la leucemia bovina (blv), y uso del mismo.
MX2019004460A (es) Artículo corroible de fondo de pozo.
WO2014068409A3 (en) Use of a cement accelerator and electric arc furnace dust in cement
BR112018013323A2 (ja) The 1 chain nucleic acid molecule which controls revelation of a pro renin gene or a pro renin receptor gene, and its use
IN2012DN05209A (ja)
PH12016501655B1 (en) Genetic loci associated with increased fertility in maize
MX2017002829A (es) Proceso para la produccion de clorotrifluoroetileno.
MX2018002031A (es) Proceso para la preparacion de 1,4-bis (etoximetil) ciclohexano.